retatrutide safety study I've been asked a lot recently about Retatrutide, so I wanted to share some clear, factual information. is not licensed in the UK. It is still in clinical trials and cannot Retatrutide Subcutaneous Fat Loss Results:

We aim to help you achieve lasting weight loss, better metabolic health, and an improved quality of life

Now here is where things get interesting for tirzepatide users

Allow them to dry completely

Check for NABP accreditation

In rare cases, GLP-1 agonists like Ozempic have been linked with eye problems, gallbladder and pancreas problems, blocked intestines, and stomach paralysis (a condition in which your stomach muscles don't contract as they should to help you digest food)

This guide walks through the full TRIUMPH program, the TRIUMPH-4 dataset, the 2026 readouts still to come, how retatrutide stacks up against tirzepatide and semaglutide on published trial data, and what the regulatory picture realistically looks like from here